85 - Antimicrobial Resistance in Latin America

Thursday, October 20, 2022

3:15 PM – 4:30 PM US ET

Location: 143 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Monica Thormann, MD

President
Asociación Panamericana de Infectología
Santo Domingo, Dominican Republic

Disclosure(s): No financial relationships to disclose
Alberto Chebabo, MD

President
Brazilian Society of Infectious Diseases
Rio de Janeiro, Rio de Janeiro, Brazil

Disclosure(s): No financial relationships to disclose
Laila Woc-Colburn, MD

Associate Professor
Emory University School of Medicine
Decatur, GA, United States

Disclosure(s): No financial relationships to disclose

Slides

Faculty(s)

Jinnethe Reyes, MSc, PhD

Professor
Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque
Bogota, Distrito Capital de Bogota, Colombia

Disclosure(s): No financial relationships to disclose

Slides
Paulo Castaneda-Mendez, MD

Infectious Diseases
Hospital Medica Sur, Distrito Federal, Mexico

Disclosure(s): No financial relationships to disclose
Ana Belen Arauz Rodriguez, MD

Associate Professor of Medicine
Medicine
Hospital Santo Tomas, Panama, Panama

Disclosure(s): AstraZenca: Advisor/Consultant (Terminated), Travel for Educational reason (Terminated); GSK: Advisor/Consultant (Ongoing); Merck / MSD: Advisor/Consultant (Terminated), Honoraria (Terminated); Pfizer Pharmaceuticals: Advisor/Consultant (Ongoing), Educational activity (Ongoing), Honoraria (Ongoing)

Slides

Disclosure(s):

Monica C. Thormann, MD: No financial relationships to disclose

Alberto Chebabo, MD: No financial relationships to disclose

Laila Woc-Colburn, MD: No financial relationships to disclose

Jinnethe Reyes, MSc, PhD: No financial relationships to disclose

Paulo Castaneda-Mendez, MD: No financial relationships to disclose

Ana Belen Arauz Rodriguez, MD: AstraZenca: Advisor/Consultant (Terminated), Travel for Educational reason (Terminated); GSK: Advisor/Consultant (Ongoing); Merck / MSD: Advisor/Consultant (Terminated), Honoraria (Terminated); Pfizer Pharmaceuticals: Advisor/Consultant (Ongoing), Educational activity (Ongoing), Honoraria (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the current resistance data and public health impact of Staphylococcus aureus, in particular MRSA, in Latin America;
summarize recent preventive and treatment efforts aimed at MDR gram negatives;
explore the emerging data and recent trends in Candida auris in Latin America

Presentations:

3:15 PM – 3:40 PM US ET

Staphylococcal Resistance in Latin America: What Do We Need to Know?
Speaker: Jinnethe Reyes, MSc, PhD – Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque
3:40 PM – 4:05 PM US ET

Gram Negative Resistance in Latin America: A Preventive and Therapeutic Approach
Speaker: Paulo Castaneda-Mendez, MD – Hospital Medica Sur
4:05 PM – 4:30 PM US ET

The Growing Threat of Candida auris
Speaker: Ana Belen Arauz Rodriguez, MD – Hospital Santo Tomas